Chronic pulmonary embolism and pulmonary hypertension

Seminars in Respiratory and Critical Care Medicine

Volumn 33, Issue 2, 2012, Pages 199-204

  Klok, Frederikus A ^a,b   Mos, Inge C M ^a,c   Van Kralingen, Klaus W ^a   Vahl, Jelmer E ^b,d   Huisman, Menno V ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDICAL CENTER HAAGLANDEN   (Netherlands)

^c MC Haaglanden ^*  (Netherlands)

^d HAGA HOSPITAL   (Netherlands)

Author keywords

chronic thromboembolic pulmonary hypertension; diagnosis; prognosis; pulmonary embolism; therapy

Indexed keywords

BOSENTAN; PROSTACYCLIN DERIVATIVE; SILDENAFIL;

ARTICLE; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DRUG EFFICACY; ENDARTERECTOMY; HEART CATHETERIZATION; HUMAN; IMAGE ANALYSIS; INCIDENCE; LUNG ANGIOGRAPHY; LUNG EMBOLISM; LUNG VASCULAR RESISTANCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; RISK FACTOR; SYMPTOM; TREATMENT OUTCOME;

ANGIOGRAPHY; CHRONIC DISEASE; ENDARTERECTOMY; HEART CATHETERIZATION; HUMANS; HYPERTENSION, PULMONARY; PROGNOSIS; PULMONARY EMBOLISM; VASCULAR RESISTANCE;

EID: 84861634719     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0032-1311800     Document Type: Article

References (51)

1. Agnelli G, Becattini C. Acute pulmonary embolism. N Engl J Med: 2010; 363 3 266 274
2. Wood KE. Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest: 2002; 121 3 877 905 (Pubitemid 34251458)
3. Klok FA, Zondag W, van Kralingen KW., et al. Patient outcomes after acute pulmonary embolism: a pooled survival analysis of different adverse events. Am J Respir Crit Care Med: 2010; 181 5 501 506
4. Klok FA, Mos ICM, Broek L., et al. Risk of arterial cardiovascular events in patients after pulmonary embolism. Blood: 2009; 114 8 1484 1488
5. Hoeper MM, Mayer E, Simonneau G, Rubin LJ. Chronic thromboembolic pulmonary hypertension. Circulation: 2006; 113 16 2011 2020
6. Fedullo PF, Auger WR, Kerr KM, Rubin LJ. Chronic thromboembolic pulmonary hypertension. N Engl J Med: 2001; 345 20 1465 1472
7. Hoeper MM, Barberà JA, Channick RN., et al. Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol: 2009; 54 1, Suppl S85 S96
8. Riedel M, Stanek V, Widimsky J, Prerovsky I. Longterm follow-up of patients with pulmonary thromboembolism: late prognosis and evolution of hemodynamic and respiratory data. Chest: 1982; 81 2 151 158 (Pubitemid 12165545)
9. Nijkeuter M, Hovens MM, Davidson BL, Huisman MV. Resolution of thromboemboli in patients with acute pulmonary embolism: a systematic review. Chest: 2006; 129 1 192 197 (Pubitemid 43265262)
10. Kaczyska A, Kostrubiec M, Pacho R, Kunikowska J, Pruszczyk P. Elevated D-dimer concentration identifies patients with incomplete recanalization of pulmonary artery thromboemboli despite 6 months anticoagulation after the first episode of acute pulmonary embolism. Thromb Res: 2008; 122 1 21 25 (Pubitemid 351601848)
11. Stein PD, Yaekoub AY, Matta F., et al. Resolution of pulmonary embolism on CT pulmonary angiography. AJR Am J Roentgenol: 2010; 194 5 1263 1268
12. Golpe R, Pérez-de-Llano LA, Castro-Añón O., et al. Right ventricle dysfunction and pulmonary hypertension in hemodynamically stable pulmonary embolism. Respir Med: 2010; 104 9 1370 1376
13. Miniati M, Monti S, Bottai M., et al. Survival and restoration of pulmonary perfusion in a long-term follow-up of patients after acute pulmonary embolism. Medicine (Baltimore): 2006; 85 5 253 262 (Pubitemid 44401458)
14. Ribeiro A, Lindmarker P, Johnsson H, Juhlin-Dannfelt A, Jorfeldt L. Pulmonary embolism. One-year follow-up with echocardiography Doppler and five-year survival analysis. Circulation: 1999; 99 10 1325 1330 (Pubitemid 29129917)
15. Olman MA, Marsh JJ, Lang IM, Moser KM, Binder BR, Schleef RR. Endogenous fibrinolytic system in chronic large-vessel thromboembolic pulmonary hypertension. Circulation: 1992; 86 4 1241 1248
16. Morris TA, Marsh JJ, Chiles PG., et al. High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension. Blood: 2009; 114 9 1929 1936
17. Morris TA, Marsh JJ, Chiles PG, Auger WR, Fedullo PF, Woods VL Jr. Fibrin derived from patients with chronic thromboembolic pulmonary hypertension is resistant to lysis. Am J Respir Crit Care Med: 2006; 173 11 1270 1275 (Pubitemid 43848399)
18. Wolf M, Boyer-Neumann C, Parent F., et al. Thrombotic risk factors in pulmonary hypertension. Eur Respir J: 2000; 15 2 395 399 (Pubitemid 30085971)
19. Egermayer P, Peacock AJ. Is pulmonary embolism a common cause of chronic pulmonary hypertension? Limitations of the embolic hypothesis. Eur Respir J: 2000; 15 3 440 448 (Pubitemid 30158178)
20. Lang I. Advances in understanding the pathogenesis of chronic thromboembolic pulmonary hypertension. Br J Haematol: 2010; 149 4 478 483
21. Moser KM, Braunwald NS. Successful surgical intervention in severe chronic thromboembolic pulmonary hypertension. Chest: 1973; 64 1 29 35
22. Tuder RM, Abman SH, Braun T., et al. Development and pathology of pulmonary hypertension. J Am Coll Cardiol: 2009; 54 1, Suppl S3 S9
23. Bogatcheva NV, Garcia JG, Verin AD. Molecular mechanisms of thrombin-induced endothelial cell permeability. Biochemistry (Mosc): 2002; 67 1 75 84
24. Pengo V, Lensing AW, Prins MH., et al. Thromboembolic Pulmonary Hypertension Study Group Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med: 2004; 350 22 2257 2264
25. Becattini C, Agnelli G, Pesavento R., et al. Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. Chest: 2006; 130 1 172 175 (Pubitemid 44116856)
26. Dentali F, Donadini M, Gianni M., et al. Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism. Thromb Res: 2009; 124 3 256 258
27. Miniati M, Monti S, Bottai M., et al. Survival and restoration of pulmonary perfusion in a long-term follow-up of patients after acute pulmonary embolism. Medicine (Baltimore): 2006; 85 5 253 262 (Pubitemid 44401458)
28. Klok FA, van Kralingen KW, van Dijk APJ, Heyning FH, Vliegen HW, Huisman MV. Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. Haematologica: 2010; 95 6 970 975
29. Tuder RM, Abman SH, Braun T., et al. Development and pathology of pulmonary hypertension. J Am Coll Cardiol: 2009; 54 1, Suppl S3 S9
30. Bonderman D, Wilkens H, Wakounig S., et al. Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J: 2009; 33 2 325 331
31. Klok FA, Tijmensen JE, Haeck ML, van Kralingen KW, Huisman MV. Persistent dyspnea complaints at long-term follow-up after an episode of acute pulmonary embolism: results of a questionnaire. Eur J Intern Med: 2008; 19 8 625 629
32. Klok FA, van Kralingen KW, van Dijk AP, Heyning FH, Vliegen HW, Huisman MV. Prevalence and potential determinants of exertional dyspnea after acute pulmonary embolism. Respir Med: 2010; 104 11 1744 1749
33. McLaughlin VV, Archer SL, Badesch DB., et al. American College of Cardiology Foundation Task Force on Expert Consensus Documents; American Heart Association; American College of Chest Physicians; American Thoracic Society, Inc; Pulmonary Hypertension Association ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol: 2009; 53 17 1573 1619
34. Huisman MV, Klok FA. Diagnostic management of clinically suspected acute pulmonary embolism. J Thromb Haemost: 2009; 7 01 312 317
35. Tunariu N, Gibbs SJ, Win Z., et al. Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med: 2007; 48 5 680 684 (Pubitemid 47604965)
36. Auger WR, Fedullo PF, Moser KM, Buchbinder M, Peterson KL. Chronic major-vessel thromboembolic pulmonary artery obstruction: appearance at angiography. Radiology: 1992; 182 2 393 398
37. Klok FA, Surie S, Kempf T., et al. A simple non-invasive diagnostic algorithm for ruling out chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. Thromb Res: 2011; 128 1 21 26 10.1016/j.thromres.2011.03.004
38. Archibald CJ, Auger WR, Fedullo PF., et al. Long-term outcome after pulmonary thromboendarterectomy. Am J Respir Crit Care Med: 1999; 160 2 523 528 (Pubitemid 29380667)
39. Jamieson SW, Kapelanski DP, Sakakibara N., et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg: 2003; 76 5 1457 1462, discussion 1462-1464
40. Corsico AG, D'Armini AM, Cerveri I., et al. Long-term outcome after pulmonary endarterectomy. Am J Respir Crit Care Med: 2008; 178 4 419 424
41. Keogh AM, Mayer E, Benza RL., et al. Interventional and surgical modalities of treatment in pulmonary hypertension. J Am Coll Cardiol: 2009; 54 1, Suppl S67 S77
42. Auger WR, Kim NH, Kerr KM, Test VJ, Fedullo PF. Chronic thromboembolic pulmonary hypertension. Clin Chest Med: 2007; 28 1 255 269, x (Pubitemid 46330546)
43. Condliffe R, Kiely DG, Gibbs JS., et al. Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med: 2008; 177 10 1122 1127 (Pubitemid 351717571)
44. Bonderman D, Skoro-Sajer N, Jakowitsch J., et al. Predictors of outcome in chronic thromboembolic pulmonary hypertension. Circulation: 2007; 115 16 2153 2158 (Pubitemid 46659067)
45. Freed DH, Thomson BM, Berman M., et al. Survival after pulmonary thromboendarterectomy: effect of residual pulmonary hypertension. J Thorac Cardiovasc Surg: 2011; 141 2 383 387
46. Ghofrani HA, Schermuly RT, Rose F., et al. Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med: 2003; 167 8 1139 1141 (Pubitemid 36459662)
47. Reichenberger F, Voswinckel R, Enke B., et al. Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension. Eur Respir J: 2007; 30 5 922 927 (Pubitemid 351194796)
48. Jaïs X, D'Armini AM, Jansa P., et al. Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension Study Group Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol: 2008; 52 25 2127 2134
49. Becattini C, Manina G, Busti C, Gennarini S, Agnelli G. Bosentan for chronic thromboembolic pulmonary hypertension: findings from a systematic review and meta-analysis. Thromb Res: 2010; 126 1 e51 e56
50. Bresser P, Fedullo PF, Auger WR., et al. Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension. Eur Respir J: 2004; 23 4 595 600 (Pubitemid 38456003)
51. Skoro-Sajer N, Bonderman D, Wiesbauer F., et al. Treprostinil for severe inoperable chronic thromboembolic pulmonary hypertension. J Thromb Haemost: 2007; 5 3 483 489 (Pubitemid 46680679)